Scientists investigated the therapeutic potential of bevacizumab in angiogenesis during osteosarcoma and the related mechanisms.
[Cell Death & Disease]
Sorry, but the selected Zotpress account can't be found.
Home Newsletters Endothelial Cell News Bevacizumab Attenuates Osteosarcoma Angiogenesis by Suppressing MIAT Encapsulated by Serum-Derived Extracellular Vesicles...
